BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vasti C, Hertig CM. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines. World J Cardiol 2014; 6(7): 653-662 [PMID: 25068025 DOI: 10.4330/wjc.v6.i7.653]
URL: https://www.wjgnet.com/1949-8462/full/v6/i7/653.htm
Number Citing Articles
1
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Comprehensive Physiology2019; : 905 doi: 10.1002/cphy.c180017
2
Francesca De luliis, Gerardo Salerno, Ludovica Taglieri, Rosina Lanza, Patrizia Cardelli, Susanna Scarpa. Circulating Neuregulin-1 and Galectin-3 can be Prognostic Markers in Breast CancerThe International Journal of Biological Markers 2017; 32(3): 333 doi: 10.5301/ijbm.5000262
3
Joshua A. Cowgill, Sanjeev A. Francis, Douglas B. Sawyer. Anthracycline and Peripartum CardiomyopathiesCirculation Research 2019; 124(11): 1633 doi: 10.1161/CIRCRESAHA.119.313577
4
Cassady E. Rupert, Kareen L.K. Coulombe. The Roles of Neuregulin-1 in Cardiac Development, Homeostasis, and DiseaseBiomarker Insights 2015; : BMI.S20061 doi: 10.4137/BMI.S20061
5
Joshua H. Decker, Radhakrishna Sura, Paul W. Snyder. Toxicologic Pathology for Non-Pathologists2019; : 279 doi: 10.1007/978-1-4939-9777-0_8
6
Ashot Avagimyan, Rosalinda Madonna, Mohammad Sheibani, Nana Pogosova, Artem Trofimenko, Olga Urazova, Laura Iop, Zinaida Jndoyan, Hasmik Yeranosyan, Anahit Aznauryan, Karmen Sahakyan, Anna Petrosyan, Ruzanna Petrosyan, Marina Tatoyan, Gayane Mkrtchyan, Elina Sulemaniayants, Goarik Meltonyan, Aleh Kuzniatsou, Rupak Mukherjee, Aysa Rezabakhsh, George Koliakos, Giulia Ottaviani, Giuseppe-Biondi Zoccai, Nizal Sarrafzadegan. Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?Vascular Pharmacology 2025; 160: 107526 doi: 10.1016/j.vph.2025.107526
7
Miguel Anjos, Marta Fontes-Oliveira, Vera M. Costa, Mário Santos, Rita Ferreira. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicityLife Sciences 2021; 280: 119760 doi: 10.1016/j.lfs.2021.119760
8
Tatiana Ammosova, Kareem Washington, Jamie Rotimi, Namita Kumari, Kahli Smith, Xiaomei Niu, Marina Jerebtsova, Sergei Nekhai. Protein Phosphatase-1 Regulates Expression of Neuregulin-1Biology 2016; 5(4): 49 doi: 10.3390/biology5040049
9
Megan Goins, Katie Lovell, Greyson Keel, Julia Cook, Robert Lust. Novel Pathogenesis and Treatments for Cardiovascular Disease2023;  doi: 10.5772/intechopen.105040
10
Song Jie, Guo Wenying, Sun Lebo, Vivek Pandey. Dehydroevodiamine Alleviates Doxorubicin‐Induced Cardiomyocyte Injury by Regulating Neuregulin‐1/ErbB SignalingCardiovascular Therapeutics 2024; 2024(1) doi: 10.1155/cdr/5538740
11
Yosuke K. Kurokawa, Steven C. George. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screeningAdvanced Drug Delivery Reviews 2016; 96: 225 doi: 10.1016/j.addr.2015.07.004
12
Toufik Abdul-Rahman, Alden Dunham, Helen Huang, Syed Muhammad Awais Bukhari, Aashna Mehta, Wireko A. Awuah, Deba Ede-Imafidon, Emiliano Cantu-Herrera, Suprateeka Talukder, Amogh Joshi, Deborah W. Sundlof, Rahul Gupta. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel TherapeuticsCurrent Problems in Cardiology 2023; 48(4): 101591 doi: 10.1016/j.cpcardiol.2023.101591
13
A. Silver, A. Palomo, T.M. Okwuosa. Cardio-Oncology2017; : 155 doi: 10.1016/B978-0-12-803547-4.00010-0
14
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Doxorubicin‐Induced Cardiomyopathy in ChildrenComprehensive Physiology 2019; 9(3): 905 doi: 10.1002/j.2040-4603.2019.tb00082.x
15
Andrew Geissler, Sergey Ryzhov, Douglas B. Sawyer. Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular diseaseClinical Science 2020; 134(19): 2623 doi: 10.1042/CS20200230
16
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola, Gabriele D’Uva. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for CardioprotectionFrontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.847012
17
Paul J. Hanson, Al Rohet Hossain, Ye Qiu, Huifang M. Zhang, Guangze Zhao, Cheng Li, Veena Lin, Saheedat Sulaimon, Marli Vlok, Gabriel Fung, Victoria H. Chen, Eric Jan, Bruce M. McManus, David J. Granville, Decheng Yang. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs CardioprotectionFrontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00265
18
Iva Minga, Hena Patel, Tochi M. Okwuosa, Niti R. Aggarwal. Sex Differences in Cardiac Diseases2021; : 505 doi: 10.1016/B978-0-12-819369-3.00028-9
19
Ahmed M. Kabel, Samir A. Salama, Almokhtar A. Adwas, Remon S. Estfanous. Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced CardiotoxicityPharmaceuticals 2021; 14(11): 1188 doi: 10.3390/ph14111188
20
Syndi Barish, Kathryn Berg, Jeffrey Drozd, Isabella Berglund-Brown, Labeeqa Khizir, Lauren K. Wasson, Christine E. Seidman, Jonathan G. Seidman, Sidi Chen, Martina Brueckner. The H2Bub1-deposition complex is required for human and mouse cardiogenesisDevelopment 2023; 150(23) doi: 10.1242/dev.201899
21
Santiago Cerrizuela, Guillermo A. Vega‐Lopez, Manuel J. Aybar. The role of teratogens in neural crest developmentBirth Defects Research 2020; 112(8): 584 doi: 10.1002/bdr2.1644
22
Younan Samuel, Aswin Babu, Foteini Karagkouni, Ayden Ismail, Sunyoung Choi, Stergios Boussios. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision MedicineCurrent Issues in Molecular Biology 2023; 45(10): 8337 doi: 10.3390/cimb45100526